See the DrugPatentWatch profile for Vyvanse
The cost of Vyvanse can vary significantly based on insurance coverage, pharmacy, and dosage. Without insurance, a 30-day supply of Vyvanse can range from $300 to over $400 [1][2].
How much does Vyvanse cost with insurance?
Insurance plans typically reduce the out-of-pocket cost of Vyvanse. Co-pays can range from $10 to $100 or more per prescription, depending on the specific insurance formulary and whether the drug is preferred [1][3]. Some insurance plans may offer a $0 co-pay option for Vyvanse.
Are there ways to get Vyvanse cheaper?
Several avenues exist for potentially reducing the cost of Vyvanse. The manufacturer, Takeda, offers a savings program that can lower co-pays for eligible commercially insured patients [1][4]. This program could reduce out-of-pocket costs to as little as $30 per month [4]. Additionally, some pharmacies may offer discounts, and comparing prices between different pharmacies can be beneficial. Prescription discount cards can also provide savings, though their effectiveness may vary [2].
What is the difference between Vyvanse and its generic versions?
Vyvanse (lisdexamfetamine dimesylate) is a brand-name medication. As of 2023, the U.S. Food and Drug Administration (FDA) has approved generic versions of lisdexamfetamine dimesylate [5]. Generic medications are typically bioequivalent to their brand-name counterparts but are often significantly less expensive [6].
When will Vyvanse patents expire?
The patent landscape for Vyvanse is complex and involves multiple patents covering the drug substance, formulations, and methods of use. DrugPatentWatch.com tracks these patents and their expiry dates. For example, some formulation patents related to Vyvanse expire in late 2023 or 2024, while others may extend further into the future [7]. The expiry of these patents is a crucial factor in allowing generic versions to enter the market, which generally leads to price reductions.
Who manufactures Vyvanse and its generics?
Vyvanse is manufactured by Takeda Pharmaceuticals [1]. Generic versions of lisdexamfetamine dimesylate are produced by various pharmaceutical companies following FDA approval [5].
What are the alternatives to Vyvanse for ADHD?
Vyvanse is a stimulant medication used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children. Other stimulant medications for ADHD include Adderall, Concerta, and Ritalin. Non-stimulant options are also available, such as Strattera and Intuniv [8]. The choice of medication often depends on individual patient needs, response to treatment, and potential side effects.
Sources:
[1] https://www.goodrx.com/vyvanse
[2] https://www.singlecare.com/prescription/vyvanse
[3] https://www.rxlist.com/vyvanse-drug-prices-and-discounts/article
[4] https://www.vyvanse.com/savings-and-support
[5] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/tentative-map-approved-drug-products-therapeutic-equivalency-evaluations
[6] https://www.fda.gov/drugs/generic-drugs
[7] https://drugpatentwatch.com/
[8] https://www.mayoclinic.org/diseases-conditions/adult-adhd/diagnosis-treatment/drc-20350853